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The composite materials based on hydroxyapatite (HA) and gelatine (Gel) with addition of silver and
zirconium oxide were obtained. The study investigates a combination of low powered ultrasonic irra-
diation and low concentration of gelatine in the co-precipitation synthesis. These composites have
different weight ratios of organic/inorganic components and may be synthesized in two ways: simple
mixing and co-precipitation. Both of which were compared.
The estimation of porosity, in vivo testing, surface morphology and phase composition as well as the
IR-analysis were provided. Hydroxyapatite was the main crystalline phase in obtained composites.
While around powdered HA-Gel composite the connective tissue capsule is formed without bone
tissue formation, HA-Gel-Ag porous composite implantation leads to formation of new bone tissue and
activation of cell proliferation. Addition of silver ions into composite material allows decreasing
inﬂammation on the ﬁrst stage of implantation and has positive effect on bone tissue formation. Some of
the obtained composite materials containing silver or ZrO2 are biocompatible. bio-resorbable and
osteoconductive with high level of porosity (75e85%).
© 2016 Elsevier B.V. All rights reserved.1. Introduction
Over 40 billions euro is annually spent on treatment of bone
tissue diseases and traumas [1] and 50% of these expenses are used
for osteoplastic materials, implants and prostheses. Thesematerials
should have biocompatible and osteoconductive properties [2].
Porosity is an essential parameter that deﬁnes the properties ofcs, National Academy of Sci-
00, Ukraine.obtained biomaterials. Solid conjunctive tissues are porous, e.g., a
porosity of the cancellous bone is from 50 to 90% (pore size is near
1 mm in diameter) [3,4]. Porous scaffolds are rather widely applied
for regeneration of the bone tissue due to migration of osteogenic
cells that contribute to bone tissue growth. The scaffolds may be
manufactured with addition of ceramic materials, metals, bio-
polymers and calcium phosphate based inorganic components like
hydroxyapatite, which is a mineral constituent of the bone tissue
[5].
Combination of organic and inorganic components [6] allows
obtaining materials with maximum biocompatibility and osteo-
conductivity. In bone tissue calcium phosphates and collagen ﬁbrils
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posite materials like hydroxyapatite/collagen are of special interest
in the bone defect replacement [7].
Today, the composites with gelatine are of great concern among
the researchers. Gelatine is a product of partial collagen hydrolysis
[2]. But in contrast to the latter, it is more stable and exhibits less
antigenicity,which allows gelatine to be applied as a component of
biomaterials [2,6,8]. Gelatine is advantageous in its availability, low
cost, biocompatibility and biodegradability [8e10]. Furthermore,
gelatine is a polyampholyte with the cationic (13% lysine and
arginine), the anionic (~12% glutamic and aspartic acid) and the
hydrophobic groups (~11% of the chain comprising leucine,
isoleucine, methionine and valine) present in ratio 1:1:1. Other part
of the chain contains glycine, proline and hydroxyproline (Fig. 1)
[8,10].
There are various methods of HA-gelatine composites prepara-
tion [11e17]: ultrasonic thermally assisted synthesis of nano hy-
droxyapatite [12], biomimetic precipitation [13]. But still the most
popular method is hydroxyapatite precipitation into a gelatine gel
or a matrix [14,15]. Limitation of the HA nanopowder dispersion
method [16] is agglomeration of HA powder in a concentrated
gelatine solution. This might cause difﬁculties for composite ma-
terial formationwith desirable structural features [17]. HA-gelatine
composites preparation by co-precipitation from aqueous solutions
with low concentrations of gelatine and addition of various com-
ponents is understudied. Particularly promising is addition of
antibacterial components [18] that allow reducing inﬂammation at
the initial stage of implantation [19].
In this work, the composite materials based on carbonate HA
and gelatine with addition of silver and zirconium (IV) oxide were
synthesized by co-precipitation and dispersion method. Obtained
samples were compared, structural features andmorphology of the
HA and gelatine based composites were determined. Potential
bioactivity of the materials was evaluated in the in vivo
experiments.2. Materials and methods
2.1. Materials and reagents
The analytically grade reagents Ca(NO3)2$4H2O, Na2HPO4$4H2O,
NaHCO3, NaOH, AgNO3, ZrO2 and pharmaceutical gelatine by
Zhengzhou Sino Chemical Co. Ltd, China, were used in the study.2.2. Synthesis of composite materials
Carbonate hydroxyapatite, which is the main mineral compo-
nent of a bone tissue [20], was used as an inorganic constituent of aFig. 1. Basic chemical struccomposite material. It was synthesized by following equation:
9 Ca(NO3)2 4H2O þ 5 Na2HPO4 4
H2O þ NaHCO3 þ 8 NaOH/ Ca9Na(PO4)5CO3(OH)2 þ 18
NaNO3 þ 107 H2O.
Gelatine was dissolved in water at 80С; then a synthesized HA
and relevant quantity of additives (samples a, d, e) were added
under ultrasonic treatment. The sample (a) contained 2.6% HA, 0.9%
ZrO2, 5.5% gelatine, 91% H2O; (d) 6.3% HA, 1.8% gelatine, 0.9% ZrO2,
0.01% Ag, 90.99% H2O; (e) 7.2% HA, 1.8% gelatine, 91% H2O.
Component ratio in dry substance was as follows: а) HA-Gel-ZrO2e
3/6/1; b) HA-Gel e 2.15/1; c) HA-Gel-Ag e 2.15/1/0.01; d) HA-Gel-
ZrO2-Ag e 7/1.99/1/0.01; e) HA-Gel e 8/2.
Composite materials (b, c) were prepared in situ by co-
precipitation of gelatine and carbonate HA from aqueous solu-
tions. The sample (b) contained 21.5% HA, 10% gelatine, 68.5% H2O;
(c) 21.5% HA, 10% gelatine, 0.1% Ag, 68.4% H2O, The sample (b) was
synthesized according to a scheme in Fig. 2 (stage 1e3).
First solution was obtained by addition of 0.84 g NaHCO3 to 0.1
М solution of Ca(NO3)2$4H2O while stirring until completely dis-
solved. Gelatine was added during the synthesis of carbonate
apatite: 5% gelatine solution (t ¼ 80 C) was added to 0.06 M so-
lution of Na2HPO4$4H2O while stirring. Throughout the whole
experiment the temperature was maintained at the same level
(second solution). The obtained solutionwas added dropwise to the
ﬁrst solution under constant stirring and then 10 M solution of
NaOH was being added until 8.0 рН was obtained.
The obtained product was a uniform ﬁne composite that was
divided into 2 parts (500 ml each). 5 ml of AgNO3 solution with
10 g L1 concentration (sample c) was added into the ﬁrst part. The
second part remained unchanged.
After that the obtained composites were rinsed with distilled
water until pH 7.3 was reached. Ageing of the obtained composites
in the solution was performed for 48 h at 22 C. Then the samples
were freeze-dried and, for comparison, the same samples were
dried in the open air.
2.3. Porosity and density determination
Porosity was determined with a liquid displacement technique
[21]. Ethanol was chosen as displacement liquid since it penetrates
the open pores and causes no expanding or deformation [22].
A sample with known dry weight (W) was immersed into a
graduated cylinder with known volume (V1) of ethanol added. The
sample was pressed down for ethanol penetration and was left
there for 24 h. Total volume of the remained ethanol and soaked
scaffold is marked as (V2) to denote liquid level in the cylinder.
Volume difference (V2eV1) is scaffold volume. A scaffold soakedture of gelatine [8,10].
Fig. 2. The synthesis scheme of composite materials HA-Gel (b), and HA-Gel-Ag (с) obtained by co-precipitation from aqueous solutions.
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remained ethanol was marked as V3. Porosity was calculated by
equation [23]:
Pð%Þ ¼ ðV1  V3ÞðV2  V3Þ
 100; (1)
For density (d) calculation of the obtained composites the
equation [24] was taken:
d ¼ WðV2  V3Þ
; (2)
Calculated results are presented with mean square deviation
that is calculated for three samples of each composite.2.4. Characterization techniques
The morphology analysis of obtained composites was provided
by scanning electron microscopy (REMMA-102, SELMI, Sumy,
Ukraine), optical microscopy (Karl Zeiss Primo Star, Karl Zeiss
Microimaging, GMBH, Germany) and digital camera (Canon Pow-
erShot A1400).
The X-ray diffraction (XRD) analysis was carried out by the X-ray
diffractometer DRON-4-07 (Bourevestnik, www.bourevestnik.ru)
connected to a computer-aided system for experiment control and
data processing. The CuKa radiation was used (wavelength
0,154 nm) with the Bragg-Brentano focusing method. Current and
voltage of the X-ray tube were 20 mA and 40 kV, respectively. The
scan was performed in a continuous registration mode with 0.02
step and 1/min scan speed in 2q range of 10e60. All experi-
mental data were processed using the DifWin-1 program package
(Etalon-TC, www.specord.ru). Phase identiﬁcation was performed
using JCPDS (Joint Committee on Powder Diffraction Standards)
card catalog.
The qualitative phase analysis was performedwith the reference
intensity ratio (RIR) method [25] to determine the concentrations
of crystallite phases. Themethod is based on the corundumnumber
e the ratio of intensities of twomain peaks of the studied phase and
synthetic corundum in their two-component 50:50 mixture. If the
main peak is overlapped, another one could be used with respect to
its relative intensity. These values (corundum number and relativeintensities) are available in the JCPDS card catalogue.
Ci ¼
 
KiIreli
Ii
Xn
i¼1
Ii
KiIreli
!1
; (3)
where Ci is the concentration of the i-phase, Ki is the corundum
number of the i-phase, Ii is the intensity of the selected peak of the
i-phase, Ireli is the relative peak intensity of the i-phase.
The molecule structural components were identiﬁed by the
Fourier IR-spectrometer “Spectrum One” (Perkin-Elmer, USA,
2003). The solid probes were pressed in KBr tablets and analyzed.
Measurements and analysis of spectra were carried out with soft-
ware of the device.2.5. In vivo study
30 Wistar rats were used for experiments and housed in vivar-
ium condition at Medical Institute of Sumy State University.
Housing of the animals and all experimental procedures were
carried out in accordance with the Directive 2010/63/EU of the
European Parliament and of the Council as of 22 September 2010 on
the Protection of Animals Used for Scientiﬁc Purposes. All materials
were sterilized with ethanol (96%) during 1 h.
Animals were divided into 5 groups, 6 rats in each (a-e). After
general anaesthesia (ketamine, 10 mg per 1 kg) the round bone
defect was performed on medial surface of tibia with a dental drill
(ø 1.1 mm) with perfusion of saline solution. Bone defect in animals
of ﬁrst groupwas ﬁlled with the composite powdermaterials (b), in
other groups e by the spongy porous materials (a, c, d, e). Skin
defect was sutured after operation and animals were put back into
the vivarium.
The animals were euthanized by ketamine overdosing
(70 mg per 1 kg). The bone with defect was ﬁxed in 10% formal-
dehyde and decalciﬁed in a mixture which contained 45 ml of
formic acid, 5 ml of formaldehyde and 45 ml H2O. Then it was dried
in alcohols of elevated concentrations and set into a parafﬁn wax.
The 12 mm thick sections were prepared and stained with haema-
toxylin and eosin. The specimens were investigated by a light mi-
croscope “OLYMPUS”. Morphometric parameters were performed
in “SEO ImageLab” software.
Table 1
Measurement results of density and porosity for the HA and gelatine based
composites.
Sample Density, d (g cm3) Porosity, P (%)
a 0.070 ± 0.03 80 ± 0.03
b 0.049 ± 0.02 80 ± 0.03
c 0.083 ± 0.01 75 ± 0.02
d 0.099 ± 0.02 75 ± 0.02
e 0.086 ± 0.01 80 ± 0.01
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Measurement results of density and porosity for the HA and
gelatine based composites are shown in Table 1. Calculated porosity
of the composites is within 75e80%, which corresponds to porosity
of a spongy bone [26].
All values are presented with standard deviations. All experi-
ments were performed at least three times and showed reliable
reproducibility.
When Agþ ions were added during synthesis, density of com-
posite materials increased. It is probably related to gelatine ﬁxation
with silver ions. Fig. 3 shows IR-spectra of composites (b, c) ob-
tained by the co-precipitation method from the aqueous solutions
since interaction between the components is possible in this type of
synthesis.
In Fig. 3 the absorption peaks located at 1092 and 1033 cm1
were originated from asymmetrical stretching (n3) of PO43 and at
566 and 603 cm1 were attributed to bending modes (n4) of PO43,
respectively [4,27]. The symmetric stretching modes (n1 and n2) of
PO43 were also observed at around 961 cm1, while a weak sharp
peak at 3573 cm1 corresponded to the stretching vibration of the
lattice OH ions [28].
In Fig. 3 c the 1658 cm1 bands is the absorption of amide I [29].
Some CO32 derived bands were observed at 1462 and 873 cm1,
respectively, which indicated that CO32 can substitute PO43 in the
lattice of HA [28]. The peak at 2923 cm1 corresponds to OeH
stretch carboxylic acids. In reference [29] authors reported thatFig. 3. IR-spectra of a) carbonate apatite; b) caassignment at 1648 cm1 corresponded to NeH bend primary
amines. Therefore, shift to 1658 cm1 could be explained by the
interaction of silver with NeH group. However, in Fig. 3 (a) peak at
1645 cm1 corresponds to OeH band in carbonate apatite. Thus, the
interaction between silver and gelatine could be possible but
cannot be conﬁrmed.
Considerable discrepancies in the composite densities are
observed in terms of the drying techniques applied. When freeze-
drying is applied, the structure of composites becomes like
porous sponge that is dense and soft (a,c,d,e). Sometimes they are
decomposed onto a powder (b) after the freeze-drying and hence
become dense and compact. Morphology of the obtained material
is shown in Fig. 4.
From general view of obtained composite materials
(Fig. 4.1ae1e) is seen that most of them are of porous (1 a, c, d) or
laminated structure (1 e). Micrographs at magniﬁcation 4
(Fig. 4.2aee) and 10 (Fig. 4.3aee) were made by optical micro-
scopy. SEM micrographs (Fig. 4.4aee) were made at
magniﬁcation 50. Porous structure is preferred for ingrowths of a
newly formed bone tissue.
XRD spectra are shown in Fig. 5 with the bar chart corre-
sponding to hydroxyapatite (JCPDS 84e1998). In samples a and
d the additional phase of zirconium oxide (JCPDS 74e815) is also
present. The symbol A marks the main peak of zirconium oxide.
The crystallinity of HA decreases with the reduction of its amount
in the samples. It should be mentioned that the superposition of
main HA peaks (2q range of 31e35) is better resolved in case of
the sample e than that of pure HA (sample f).
There are some limitations in the experimental protocol. As
crystallinity of the analyzed samples is low, the obtained X-ray
diffraction spectra are not of sufﬁcient resolution to provide com-
plex characterization of apatite structure, e.g., it is impossible to
estimate average crystallite sizes in the majority of crystallographic
planes or to calculate HA unit cell parameters with sufﬁcient ac-
curacy for some of the samples. The presence of Ag could not be
conﬁrmed by the XRD because of its small concentration (0.01%) to
prevent the toxic effect on the organism. Further investigations
should include the separation of size-strain contributions to therbonate containing HA-Gel; c) HA-Gel-Ag.
Fig. 4. Morphology of obtained composites, general view: (1a) HA-Gel-ZrO2, (1b) HA-Gel, (1c) HA-Gel-Ag, (1d) HA-Gel-ZrO2-Ag, (1e) HA-Gel and optical micrographs of listed
composite materials at magniﬁcation 4 (2ae2e) and at magniﬁcation 10 (3ae3e). SEM micrographs (4ae4e).
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XRD spectra. Moreover, annealing of the samples in order should
help to determine whether the initial apatite is calcium deﬁcient or
not.
The form of the multiplet at ~33 2q could be explained by the
presence of gelatin, which decreases the crystallinity of hydroxy-
apatite [30,31].
Calculated crystalline phases concentrations are presented in
Table 2.
Crystallite sizes in (0 0 2) plane of HA were calculated using
Scherrer equation (Table 3) except for the sample a due to its poor
crystallinity.
The obtained data show mainly the decrease of crystallite sizes
of HA with the increase of the concentration of other components.These results are in a good agreement with work [32] conﬁrming
that the addition of gelatine leads to the decrease of crystallinity,
which is indicated by the crystallite sizes and X-ray diffraction
spectra.
Some authors [33] claimed that 0.1 mg/g was a health advisory
level for silver. Ionic silver given as AgNO3 was lethal to lab mice
and rabbits at 13.9 and 20mg/kg bodyweight, respectively. Toxicity
of silver resulting from drinking water ingestion in rats is
400 mg L1 [34,35].
Cytocompatibility, osteoinduction and bonemineralization (ALP
and osteocalcin assay) of HAe10% Ag composites were illustrated
[36]. Our composite materials contain 0.01e0.1% of silver. Such
amount of silver is non-toxic but has antibacterial activity and
decreases inﬂammation at the initial stage of implantation.
Fig. 5. XRD patterns of synthesized composites: a) HA-Gel-ZrO2; b) HA-Gel; c) HA-Gel-Ag; d) HA-Gel-ZrO2-Ag; e) HA-Gel, f) pure HA.
Table 2
Phase concentrations according to the RIR method.
Phase concentration, % Samples
a d
HA 70.6 86.6
ZrO2 29.4 13.4
Table 3
Crystallite sizes of HA after Scherrer.
Samples a b c d e f
Crystallite sizes, nm e 20.5 23.2 22.8 24.7 29.5
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Zirconium materials are widely used as implant materials. Zirco-
nium compounds are generally considered to be of low toxicity.
In vitro tests have shown that zirconia has a lower toxicity than
titanium oxide. Their cytotoxicity, carcinogenicity, mutagenic or
chromosomal alterations in ﬁbroblasts or blood cells has not been
observed [37].
The histological analysis of bone tissue was performed after 21
days of the implantation and is presented in Fig. 6. Composite
material (b) was implanted as a powder, while samples (a, c, d, e) e
as a porous sponge. After 21 days since implantation the composite
materials (a) and (c), the defect was ﬁlled with newly-formed bone
tissue with irregular staining as compared to the hosting bone.
There was a network of vessels visible inside the new bone tissue
and red bone marrow cells ﬁlling intertrabecular spaces. The
newly-formed tissue was rich in osteoblasts indicating active
remodelling process [38].
The connective-tissue capsule was formed around sample (b)
within 21 days after implantation. It was made by random ori-
ented collagen ﬁbrils and had thickness of 28.65 ± 14.55 mm.
There were some vessels and ﬁbroblasts, lymphocytes and neu-
trophiles visualized in the connective-tissue capsule and some
macrophages near the area contacting with the implanted ma-
terial. There was no tissue ingrowth and cells migration into theimplant pores, which indicated the absence of osteoconductive
properties needed for successful implant ingrowths in the bone
tissue [39].
Results of material 1 (d) implantation are presented in Fig. 6 (d
and 1d). Partial biodegradation of material and formation of the
connective-tissue capsule were observed after 21 days of implan-
tation. Pores of the material were ﬁlled with a connective tissue
that had a high density of leucocytes and macrophages. The newly-
formed bone tissue was visualized around remnant of the com-
posite material. The vascular network that complicates regenera-
tion process was not observed. Since angiogenesis is connected
with the bone healing process, its suppression leads to decelerated
healing [40].
The composite material (e) was completely substituted by the
newly-formed bone tissue up to 21 days after implantation. New
bone tissue had irregular staining that may indicate incomplete
mineralization. Being a source of osteogenic cells [41], a lot of
vessels were observed in the new tissue. In comparison to the
hosting bone, the new bone tissue had a large amount of osteo-
blasts participating in remodelling of the newly-formed bone
tissue.
After implantation, the samples (b), (d) did not reveal osteo-
conductive properties, and the connective-tissue capsule was
formed around the implant. Although the composite materials (b
and е) contained the same components, the composite (b) was
introduced as a powder, the composite (a) e as a sponge. Slow
biodegradation was observed for both cases. Given that porosity of
the samples was sufﬁcient, degradation of the properties may be
explained by increased density. This feature may slow down or
even prevent the vascular ingrowth, therefore, osteogenic elements
slowly penetrate the defect zone [42].
As the composites (а), (с), (е) were introduced into the bone
defect, there was no any sign of inﬂammation in the implantation
zone and in neighbouring tissues by the 21st day. The biocompat-
ibility of the composites with bone tissue was observed. Full
biodegradation of the introduced composites takes place here, as
well. Formation of a tubular-bone tissue at such an early stage of
implantation indicates the apparent reparative and haemostatic
features of the composites.
Fig. 6. Implant site after 3 weeks of implantation: (a, 1a) HA-Gel-ZrO2, (b, 1b) HA-Gel, (c, 1c) HA-Gel-Ag, (d, 1d) HA-Gel-ZrO2-Ag, (e, 1e) HA-Gel (a-e magniﬁcation 40; 1a-1e
magniﬁcation x 200 of rectangular area). 1 is a defect zone, 2 is an implant, 3 is a newly-formed bone, 4 is a hosting bone, 5 are osteocytes, 6 is intertrabecular space, 7 are vessels, 8
is a connective-tissue capsule.
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The study concerns comparison of the HA and gelatine based
compositematerials obtained via ultra-soundmixing and in situ co-
precipitation from aqueous solutions. Some materials like а) HA-
Gel-ZrO2, с) HA-Gel-Ag, е) HA-Gel have biodegradation and reveal
osteoconductive features. This allows considering both methods as
appropriate for apatite formation. Formation of the composites by
co-precipitation of HA with gelatine gives porous, biocompatible,
biodegradable HA-Gel-Ag and HA-Gel materials. The calculated
porosity of the obtained materials was about 75e80% which cor-
responds to the porosity of a spongy bone.
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